BioSpace News Archive

SCB-808 is a proposed biosimilar of Enbrel® (etanercept) being developed in the prefilled syringe formulation for the treatment of rheumatoid arthritis and other autoimmune diseases.

Halo Labs announced the appointment of Robert Wicke as Chief Executive Officer.

RXI-109 is a self-delivering RNAi (sd-rxRNA®) compound that targets connective tissue growth factor (CTGF), a key regulator of fibrosis and scar formation.

Decision Marks Latest Once-Daily, Oral Treatment of Thrombocytopenia in Adults with Chronic Liver Disease Scheduled to Undergo a Procedure

Acacia Diversified Holdings, Inc., through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ) and Eufloria Medical of Tennessee, Inc. (Eufloria) is pleased to announce that the company has completed the acquisition of MEDAHUB Operations Group, Inc. and MEDAHUB, Inc., technology companies complete with a current compounding pharmacy license in Florida.

Vascular Graft Solutions announces today that John Radcliffe hospital in Oxford, is the first center in the UK to use its VEST technology to externally support vein grafts in patients undergoing coronary bypass surgery.

Novel data analysis methods will automate biomarker discovery to predict patient response in clinical trials

The new model offers innovative enhancements designed to re-engineer scrub management and distribution for hospitals and health systems.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Menlo Therapeutics Inc.

The IVD industry has struck back, so to speak, at the American Association for Clinical Chemistry this year.